Arrowhead Pharmaceuticals Statistics
Total Valuation
ARWR has a market cap or net worth of $3.51 billion. The enterprise value is $3.11 billion.
| Market Cap | 3.51B |
| Enterprise Value | 3.11B |
Important Dates
The next estimated earnings date is Monday, August 5, 2024, after market close.
| Earnings Date | Aug 5, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ARWR has 124.20 million shares outstanding. The number of shares has increased by 14.00% in one year.
| Shares Outstanding | 124.20M |
| Shares Change (YoY) | +14.00% |
| Shares Change (QoQ) | +14.77% |
| Owned by Insiders (%) | 4.47% |
| Owned by Institutions (%) | 79.05% |
| Float | 110.69M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 111.11 |
| PS Ratio | 99.09 |
| Forward PS | 24.25 |
| PB Ratio | 7.27 |
| P/FCF Ratio | n/a |
| PEG Ratio | -1.32 |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 87.69 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.31, with a Debt / Equity ratio of 0.25.
| Current Ratio | 8.31 |
| Quick Ratio | n/a |
| Debt / Equity | 0.25 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -19.47 |
Financial Efficiency
Return on equity (ROE) is -147.10% and return on invested capital (ROIC) is -78.61%.
| Return on Equity (ROE) | -147.10% |
| Return on Assets (ROA) | -59.90% |
| Return on Capital (ROIC) | -78.61% |
| Revenue Per Employee | $67,568 |
| Profits Per Employee | -$896,741 |
| Employee Count | 525 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -546,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -18.14% in the last 52 weeks. The beta is 0.94, so ARWR's price volatility has been similar to the market average.
| Beta (5Y) | 0.94 |
| 52-Week Price Change | -18.14% |
| 50-Day Moving Average | 25.37 |
| 200-Day Moving Average | 27.62 |
| Relative Strength Index (RSI) | 59.48 |
| Average Volume (20 Days) | 1,142,262 |
Short Selling Information
The latest short interest is 8.90 million, so 7.16% of the outstanding shares have been sold short.
| Short Interest | 8.90M |
| Short Previous Month | 9.45M |
| Short % of Shares Out | 7.16% |
| Short % of Float | 8.04% |
| Short Ratio (days to cover) | 7.14 |
Income Statement
In the last 12 months, ARWR had revenue of $35.47 million and -$470.79 million in losses. Loss per share was -$4.24.
| Revenue | 35.47M |
| Gross Profit | 35.47M |
| Operating Income | -473.77M |
| Pretax Income | -471.34M |
| Net Income | -470.79M |
| EBITDA | -432.38M |
| EBIT | -448.30M |
| Loss Per Share | -$4.24 |
Balance Sheet
The company has $523.11 million in cash and $118.92 million in debt, giving a net cash position of $404.20 million or $3.25 per share.
| Cash & Cash Equivalents | 523.11M |
| Total Debt | 118.92M |
| Net Cash | 404.20M |
| Net Cash Per Share | $3.25 |
| Equity (Book Value) | 483.79M |
| Book Value Per Share | 3.90 |
| Working Capital | 476.48M |
Cash Flow
In the last 12 months, operating cash flow was -$256.92 million and capital expenditures -$213.24 million, giving a free cash flow of -$470.16 million.
| Operating Cash Flow | -256.92M |
| Capital Expenditures | -213.24M |
| Free Cash Flow | -470.16M |
| FCF Per Share | -$3.81 |
Margins
Gross margin is 100.00%, with operating and profit margins of -1,335.58% and -1,327.18%.
| Gross Margin | 100.00% |
| Operating Margin | -1,335.58% |
| Pretax Margin | -1,328.71% |
| Profit Margin | -1,327.18% |
| EBITDA Margin | -1,218.90% |
| EBIT Margin | -1,263.79% |
| FCF Margin | -1,325.41% |
Dividends & Yields
ARWR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -14.00% |
| Shareholder Yield | -14.00% |
| Earnings Yield | -13.39% |
| FCF Yield | -13.38% |
Analyst Forecast
The average price target for ARWR is $44.25, which is 56.36% higher than the current price. The consensus rating is "Buy".
| Price Target | $44.25 |
| Price Target Difference | 56.36% |
| Analyst Consensus | Buy |
| Analyst Count | 10 |
| Revenue Growth Forecast (5Y) | 28.10% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on November 17, 2011. It was a reverse split with a ratio of 1:10.
| Last Split Date | Nov 17, 2011 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
ARWR has an Altman Z-Score of 1.79 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.79 |
| Piotroski F-Score | 2 |